v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 120,117,862 $ 201,647,394
Accounts receivable, less allowance for credit losses of zero as of September 30, 2022 and December 31, 2021 1,548,196 149,776
Other receivable 15,000,000 0
Inventory, net 11,567,607 10,067,367
Prepaid expenses and other current assets 14,946,935 4,357,829
Total current assets 163,180,600 216,222,366
Property, plant and equipment, net 17,047,641 7,897,807
Investment in Tropos 10,000,000 0
Lease right-of-use assets 11,476,927 1,538,852
Other assets 176,310 2,479,865
Total Assets 201,881,478 228,138,890
Current liabilities:    
Accounts payable 7,728,111 7,849,607
Accrued and other current liabilities 44,825,969 14,752,827
Accrued commissions 3,375,000 0
Warranty liability 3,339,484 4,583,916
Current portion of lease liabilities 1,105,016 363,714
Total current liabilities 60,373,580 27,550,064
Deferred revenue, long-term 1,505,000 0
Lease liabilities, long-term 8,736,715 1,191,053
Convertible notes, at fair value 0 24,705,000
Total Liabilities 70,615,295 53,446,117
Commitments and contingencies
Stockholders’ Equity:    
Series A preferred stock, par value $0.001 per share, 75,000,000 shares authorized, zero shares issued and outstanding as of September 30, 2022 and December 31, 2021 0 0
Common stock, par value $0.001 per share, 250,000,000 shares authorized, 160,448,077 shares issued and outstanding as of September 30, 2022 and 151,915,455 shares issued and outstanding as of December 31, 2021 160,448 151,916
Additional paid-in capital 720,100,887 686,318,201
Accumulated deficit (588,995,152) (510,374,844)
Accumulated other comprehensive loss 0 (1,402,500)
Total stockholders’ equity 131,266,183 174,692,773
Total Liabilities and Stockholders’ Equity $ 201,881,478 $ 228,138,890

Source